Pediatrix Medical Group, Inc. (NYSE:MD) Short Interest Down 22.8% in December

Pediatrix Medical Group, Inc. (NYSE:MD) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 2,300,000 shares, a decrease of 22.8% from the November 30th total of 2,980,000 shares. Based on an average daily volume of 758,400 shares, the days-to-cover ratio is presently 3.0 days. Approximately 2.7% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Mizuho increased their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Tuesday, November 19th. Deutsche Bank Aktiengesellschaft raised their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Truist Financial upped their price objective on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a report on Monday, November 4th. Jefferies Financial Group lifted their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Finally, Macquarie started coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target for the company. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and an average price target of $16.42.

Insider Buying and Selling

In other news, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the sale, the director now owns 138,683 shares in the company, valued at $2,128,784.05. This trade represents a 16.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Mary Ann E. Moore sold 8,108 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $16.00, for a total transaction of $129,728.00. Following the completion of the transaction, the executive vice president now directly owns 135,810 shares in the company, valued at $2,172,960. This represents a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in MD. nVerses Capital LLC purchased a new position in shares of Pediatrix Medical Group during the 2nd quarter worth approximately $31,000. Innealta Capital LLC acquired a new stake in shares of Pediatrix Medical Group during the 2nd quarter worth about $33,000. Quest Partners LLC grew its holdings in shares of Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after buying an additional 622 shares in the last quarter. Quarry LP raised its position in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after buying an additional 1,662 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new position in shares of Pediatrix Medical Group during the second quarter valued at approximately $72,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Performance

MD traded down $0.17 on Friday, reaching $13.49. The company had a trading volume of 430,944 shares, compared to its average volume of 861,421. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.83. Pediatrix Medical Group has a 1 year low of $6.62 and a 1 year high of $16.41. The stock has a market capitalization of $1.16 billion, a PE ratio of -4.41, a P/E/G ratio of 2.00 and a beta of 1.57. The stock has a 50-day moving average price of $14.30 and a 200-day moving average price of $11.23.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The company had revenue of $511.20 million during the quarter, compared to analysts’ expectations of $498.87 million. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The firm’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.29 earnings per share. As a group, research analysts forecast that Pediatrix Medical Group will post 1.26 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.